๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Mitochondria: Aspects for neuroprotection

โœ Scribed by Paul E. Hart; Anthony H.V. Schapira


Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
97 KB
Volume
46
Category
Article
ISSN
0272-4391

No coin nor oath required. For personal study only.

โœฆ Synopsis


The understanding of mitochondrial biology and, subsquently, the role of mitochondrial pathology in human disease has increased exponentially over the past 30 years. As insight has increased, so attention has begun to shift to the possibilities for treating mitochondrially based disorders. There are a number of archetypal mitochondrial diseases, each associated with specific mitochondrial DNA mutations, deletions, or depletions. In addition there are a number of disorders, mainly neurodegenerative in nature, in which mitochondrial dysfunction appears to play a pivotal role. Mitochondrial structure and function are discussed. Treatment of the archetypal mitochondrial disorders and other neurogenerative conditions is reviewed, with specific emphasis on the prospects for neuroprotection.


๐Ÿ“œ SIMILAR VOLUMES


Vaccination for T cell-mediated neuropro
โœ Michal Schwartz ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 60 KB

Degenerative diseases of the central nervous system (CNS) are characterized by progressive degeneration, which continues even after the primary causative factor has been identified and neutralized or removed. The progressive degeneration is thought to be a self-perpetuating process, attributable in

Imaging end points for monitoring neurop
โœ David J. Brooks ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 312 KB ๐Ÿ‘ 2 views

In this review, the potential role of positron emission tomography and single-photon emission computed tomography as biological markers for following the progression of Parkinson's disease (PD) is discussed, and their value for assessing the efficacy of putative neuroprotective agents in PD is consi